Analysis: Drug company and scientific partners at Oxford University have strongly pushed back against German press report Coronavirus - latest updates See all our coronavirus coverage A row has broken out after German newspapers suggested the Oxford/AstraZeneca vaccine might have a lower efficacy among the over-65s. Below we take a look at the claims, and whether we should be concerned.
Why experts say there is no basis to claims in Germany about efficacy of AstraZeneca vaccine
The Guardian - 26 Jan 2021 15:39
Analysis: Drug company and scientific partners at Oxford University have strongly pushed back against German press report Coronavirus - latest updates See all our coronavirus coverage A row has broken out after German newspapers suggested the Oxford/AstraZeneca vaccine might have a lower efficacy among the over-65s. Below we take a look at the claims, and whether we should be concerned.
Share this Article
Recommended